JPMorgan analyst Robbie Marcus initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Overweight rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage